Sign in Subscribe
Class action lawsuits

Centene Corporation Faces Class Action Lawsuit Over Alleged Misleading Investors

Strategic Insights

— 2 min read

Centene Corporation, a leading healthcare enterprise, is facing a class action lawsuit alleging that the company misled investors regarding its business prospects. The lawsuit, filed on behalf of investors who purchased or acquired Centene securities between December 12, 2024 and June 30, 2025, claims that the company created a false impression of reliable information about its projected revenue outlook and anticipated growth. However, an analysis of over two-thirds of Centene's marketplace share revealed lower-than-anticipated enrollment and increased aggregate market morbidity. As a result, Centene withdrew its 2025 guidance, stating that the preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75. The news caused Centene's common stock to decline by over 40%.

Key Takeaways:

  • Centene Corporation is facing a class action lawsuit alleging that the company misled investors regarding its business prospects.
  • The lawsuit claims that Centene created a false impression of reliable information about its projected revenue outlook and anticipated growth.
  • An analysis of over two-thirds of Centene's marketplace share revealed lower-than-anticipated enrollment and increased aggregate market morbidity.
  • On July 1, 2025, Centene withdrew its 2025 guidance, stating that the preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75.
  • Centene's common stock declined by over 40% following the news.
  • Shareholders who want to serve as lead plaintiff for the class should contact the firm.
  • The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.
  • Shareholders can remain absent class members if they choose not to participate.
  • The representation is on a contingency fee basis, meaning that all representation is on a fee basis where shareholders pay no fees or expenses if they choose to take no action.

Statistics:

  • 72% of Centene's marketplace membership was lower than expected.
  • Two-thirds of Centene's marketplace share revealed lower-than-anticipated enrollment and increased aggregate market morbidity.
  • Over 40% decline in Centene's common stock on July 2, 2025, compared to July 1, 2025.
  • $1.8 billion reduction in Centene's previously issued guidance.
  • $44.78 per share decline in Centene's common stock on July 2, 2025, compared to $56.65 per share on July 1, 2025.
  • 22 states analyzed in the preliminary analysis.

Sources:

  • [PRNewswire, "Reminds Stockholders of Class Action Lawsuit Against Centene Corporation (NYSE: CNC)", July 23, 2025]
  • [Robbins LLP, "Investigating Allegations that Centene Corporation (CNC) Misled Investors Regarding its Business Prospects", July 2025]
  • [Robbins LLP, "Shareholders Who Want to Serve as Lead Plaintiff for the Class Should Contact the Firm", July 2025]

Read more